 0001062993-17-001043.txt : 20170217 0001062993-17-001043.hdr.sgml : 20170217 20170217160116 accession number:		0001062993-17-001043 conformed submission type:	sc 13d public document count:		7 filed as of date:		20170217 date as of change:		20170217 group members:		alignvest partners master fund gp inc. group members:		alignvest partners master fund lp subject company:	 	company data:	 		company conformed name:			trilogy international partners inc. 		central index key:			0001689382 		standard industrial classification:	blank checks [6770] 		irs number:				000000000 		state of incorporation:			a6 		fiscal year end:			1231 	filing values: 		form type:		sc 13d 		sec act:		1934 act 		sec file number:	005-89884 		film number:		17621318 	business address:	 		street 1:		155 - 108 avenue ne 		street 2:		suite 400 		city:			bellevue 		state:			wa 		zip:			98004 		business phone:		425 458-5900 	mail address:	 		street 1:		155 - 108 avenue ne 		street 2:		suite 400 		city:			bellevue 		state:			wa 		zip:			98004 	former company:	 		former conformed name:	alignvest acquisition corp 		date of name change:	20161104 filed by:		 	company data:	 		company conformed name:			alignvest management corp 		central index key:			0001698269 		irs number:				000000000 		state of incorporation:			a6 		fiscal year end:			1231 	filing values: 		form type:		sc 13d 	business address:	 		street 1:		100 king street west 		street 2:		70th floor 		city:			toronto 		state:			a6 		zip:			m5x 1c7 		business phone:		416-360-6390 	mail address:	 		street 1:		100 king street west 		street 2:		70th floor 		city:			toronto 		state:			a6 		zip:			m5x 1c7 sc 13d 1 sched13d-amc.htm form sc 13d trilogy international partners inc.: sc 13d - filed by newsfilecorp.com united states securities and exchange commission washington, d.c. 20549 schedule 13d* (amendment no. __) information to be included in statements filed pursuant to rule 13d-1(a) and amendments thereto filed pursuant to rule 13d-2(a) trilogy international partners inc. (name of issuer) common shares, no par value (title of class of securities) 89621t108 (cusip number) donald belovich stikeman elliott llp 5300 commerce court west, 199 bay street toronto, on, canada m5l 1b9 (416) 869-5606 (name, address and telephone number of person authorized to receive notices and communications) february 7, 2017 (date of event which requires filing of this statement) if the filing person has previously filed a statement on schedule 13g to report the acquisition that is the subject of this schedule 13d, and is filing this schedule because of rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box: [ ] note: schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. see rule 13d-7 for other parties to whom copies are to be sent. * the remainder of this cover page shall be filled out for a reporting person&#146;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. the information required on the remainder of this cover page shall not be deemed to be &#147;filed&#148; for the purpose of section 18 of the securities exchange act of 1934, as amended (&#147; exchange act &#148;) or otherwise subject to the liabilities of that section of the exchange act but shall be subject to all other provisions of the exchange act (however, see the notes). page 1 of 14 pages schedule 13d cusip no. 89621t108 1 names of reporting persons alignvest management corporation 2 check the appropriate box if a member of a group* (a) [x] (b) [ ] 3 sec use only [ ] 4 source of funds (see instructions) wc 5 check if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) [ ] 6 citizenship or place of organization ontario, canada number of shares beneficially owned by each reporting person with 7 sole voting power 7,084,800 1 8 shared voting power 2,751,000 9 sole dispositive power 7,084,800 1 10 shared dispositive power 2,751,000 11 aggregate amount beneficially owned by each reporting person 9,835,800 1 12 check box if the aggregate amount in row (11) excludes certain shares* [ ] 13 percent of class represented by amount in row (11) 11.7% 2 14 type of reporting person* co ____________________ 1 includes 407,040 common shares issuable upon exercise of outstanding warrants held by the reporting person. 2 based on 44,177,149 currently outstanding common shares, 407,040 commons shares issuable upon exercise of outstanding warrants held by the reporting person and 39,334,917 common shares issuable upon redemption of currently outstanding class c units of trilogy international partners llc (which the holders thereof may redeem, subject to the expiration of certain &#147;lock-up&#148; periods, either for common shares or the cash equivalent thereof, such form of consideration to be determined by trilogy international partners llc). the class c units of trilogy international partners llc have indirect voting rights in the issuer on an as-redeemed basis. see items 3 and 5 of this schedule 13d. page 2 of 14 pages schedule 13d cusip no. 89621t108 1 names of reporting persons alignvest partners master fund lp 2 check the appropriate box if a member of a group* (a) [x] (b) [ ] 3 sec use only [ ] 4 source of funds (see instructions) wc 5 check if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) [ ] 6 citizenship or place of organization cayman islands number of shares beneficially owned by each reporting person with 7 sole voting power 0 8 shared voting power 2,751,000 9 sole dispositive power 0 10 shared dispositive power 2,751,000 11 aggregate amount beneficially owned by each reporting person 2,751,000 12 check box if the aggregate amount in row (11) excludes certain shares* [ ] 13 percent of class represented by amount in row (11) 3.3% 1 14 type of reporting person* pn ____________________ 1 based on 44,177,149 currently outstanding common shares and 39,334,917 common shares issuable upon redemption of currently outstanding class c units of trilogy international partners llc (which the holders thereof may redeem, subject to the expiration of certain &#147;lock-up&#148; periods, either for common shares or the cash equivalent thereof, such form of consideration to be determined by trilogy international partners llc). the class c units of trilogy international partners llc have indirect voting rights in the issuer on an as-redeemed basis. see items 3 and 5 of this schedule 13d. page 3 of 14 pages schedule 13d cusip no. 89621t108 1 names of reporting persons alignvest partners master fund gp inc. 2 check the appropriate box if a member of a group* (a) [x] (b) [ ] 3 sec use only [ ] 4 source of funds (see instructions) af 5 check if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) [ ] 6 citizenship or place of organization cayman islands number of shares beneficially owned by each reporting person with 7 sole voting power 0 8 shared voting power 2,751,000 9 sole dispositive power 0 10 shared dispositive power 2,751,000 11 aggregate amount beneficially owned by each reporting person 2,751,000 12 check box if the aggregate amount in row (11) excludes certain shares* [ ] 13 percent of class represented by amount in row (11) 3.3% 1 14 type of reporting person* co ____________________ 1 based on 44,177,149 currently outstanding common shares and 39,334,917 common shares issuable upon redemption of currently outstanding class c units of trilogy international partners llc (which the holders thereof may redeem, subject to the expiration of certain &#147;lock-up&#148; periods, either for common shares or the cash equivalent thereof, such form of consideration to be determined by trilogy international partners llc). the class c units of trilogy international partners llc have indirect voting rights in the issuer on an as-redeemed basis. see items 3 and 5 of this schedule 13d. page 4 of 14 pages item 1. security and issuer this schedule 13d relates to the common shares, without par value (the &#147; common shares &#148;), of trilogy international partners inc., a corporation continued under the laws of british columbia, canada (the &#147; issuer &#148;), with its principal executive offices located at 105 &#150; 108 th avenue ne, suite 400, bellevue, washington 98004. item 2. identity and background (a) this schedule 13d is being filed jointly on behalf of the following reporting persons (collectively, the &#147; reporting persons &#148;) (i) alignvest management corporation, a corporation organized under the laws of ontario, canada (&#147; amc &#148;), (ii) alignvest partners master fund lp, a cayman islands exempted company (&#147; apmflp &#148;), and (iii) alignvest partners master fund gp inc., a cayman islands exempted company (&#147; apmfgp &#148;) which is the general partner of apmflp and is a wholly-owned subsidiary of amc. a joint filing agreement among the reporting persons is attached as exhibit 1 hereto. as a result of the existing relationships described under this item 2 and the transactions described in item 3, the reporting persons may be deemed to constitute a &#147;group&#148; within the meaning of rule 13d-5(b) under the exchange act. however, neither the filing of this schedule 13d nor anything contained herein shall be construed as an admission that all or any of the reporting persons constitute a &#147;group&#148; within the meaning of rule 13d-5(b) under the exchange act. each of the reporting persons is responsible for the completeness and accuracy of the information concerning it contained herein, but is not responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. each of the reporting persons expressly disclaims beneficial ownership of securities held by any person or entity other than, to the extent of any pecuniary interest therein, the various accounts under such reporting person&#146;s management and control. (b) the business address of amc is suite 7050, 100 king street west, first canadian place, toronto, ontario, canada m5x 1c7. the business address of each of apmflp and apmfgp is ugland house, grand cayman, cayman islands, ky1-1104. (c) the principal business of amc is asset management. the principal business of apmflp is to pursue investments for its partners&#146; capital. the principal business of apmfgp is acting as general partner of apmflp. (d) during the past five years, none of the reporting persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) during the past five years, none of the reporting persons has been a party to any civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which it is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) amc is a corporation organized under the laws of ontario, canada. apmflp and apmfgp are both cayman islands exempted companies. the name, business address, present principal occupation or employment and citizenship of each of the directors, executive officers and control persons of each reporting person is set forth on schedule a hereto. to the best of the knowledge of the reporting persons, none of the persons listed in schedule a has, during the past five years, been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree or final order enjoining the person from future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or a finding of any violation of federal or state securities laws. page 5 of 14 pages item 3. source and amount of funds or other consideration. on february 7, 2017, amc acquired 6,677,760 common shares (&#147; amc&#146;s acquired issuer shares &#148;) and 407,040 warrants ( &#147; amc&#146;s acquired issuer warrants &#148;) for common shares of the issuer pursuant to the completion of a court approved statutory plan of arrangement under the business corporations act (ontario) (the &#147; arrangement &#148;), and the terms of an arrangement agreement dated november 1, 2016, (as amended, the &#147; arrangement agreement &#148;), between trilogy international partners llc (&#147; trilogy llc &#148;) and the issuer (formerly known as alignvest acquisition corporation) (&#147; alignvest &#148;; its name was changed upon consummation of the arrangement to the current name of the issuer). 6,677,760 class b shares of alignvest and 407,040 warrants for class b shares of alignvest which amc acquired contemporaneously with or prior to the 2015 initial public offering of alignvest for an aggregate purchase price of cad$8,162,685 using funds from capital contributions by its founders were converted into amc&#146;s acquired issuer shares and amc&#146;s acquired issuer warrants, respectively, upon the consummation of the arrangement. alignvest was a canadian special purpose acquisition corporation (spac) for which amc was the sponsor, and the arrangement was a business combination (structured for u.s. tax purposes as an &#147;up-c&#148; transaction) which constituted the qualifying acquisition effected by alignvest. on february 7, 2017, in a private placement by alignvest that was completed in connection with and immediately prior to the consummation of the arrangement, apmflp acquired 2,751,000 class b shares of alignvest at a subscription price of cad$10.00 per share, or us$7.69 per share based on the exchange rate on that day. apmflp obtained the funds used for this purchase from capital contributions by its partners. as a result of the consummation of the arrangement, the 2,751,000 class b shares of alignvest which apmflp previously held were converted into 2,751,000 common shares of the issuer (&#147; apmflp&#146;s acquired issuer shares &#148;). apmflp did not own any securities of the issuer prior to the completion of the arrangement. the general partner of apmflp is apmfgp, which is a wholly-owned subsidiary of amc. accordingly, apmfgp and amc may be deemed to share control or direction over the apmflp&#146;s acquired shares owned by apmflp. the information set forth in the second paragraph of item 2(a) is incorporated by reference into this item 3. item 4. purpose of transaction. amc&#146;s acquired issuer shares and amc&#146;s acquired issuer warrants, and apmflp&#146;s acquired issuer shares, were acquired in connection with the completion of the arrangement. item 3 is incorporated by reference into this item 4. apmflp had acquired its class b shares of alignvest, and holds its apmflp&#146;s acquired issuer shares, for investment purposes. each of the reporting persons, however, expects to evaluate on an ongoing basis the issuer&#146;s financial condition, business, operations, prospects, the market price of the issuer&#146;s securities, conditions in the securities markets generally, general economic and industry conditions and other factors. depending on market conditions and other factors, amc and/or apmflp may from time to time acquire additional securities of the issuer or dispose of securities of the issuer in the open market, or by private agreement or otherwise. except as set forth in this schedule 13d and in connection with the arrangement described above, the reporting persons have no plan or proposals that relate or would result in any of the transactions described in subparagraphs (a) through (j) of item 4 of schedule 13d. the reporting persons reserve the right to formulate plans and/or make proposals, and take such actions with respect to their investment in the issuer, including any or all of the actions set forth in paragraphs (a) through (j) of item 4 of schedule 13d. the reporting persons may at any time reconsider and change their plans or proposals relating to the foregoing. item 5. interest in securities of the issuer. (a) and (b) as a result of the consummation of the arrangement and the relationships described herein, (i) amc beneficially owns and has sole voting and investment power over 7,084,800 common shares (which includes 407,040 warrants for common shares) and may be deemed to share voting and investment power over 2,751,000 common shares held by apmflp, for a total of 9,835,800 common shares, representing 11.7% of the issued and outstanding common shares after adding to the 44,177,149 outstanding common shares the 407,040 common shares issuable upon exercise of the 407,040 warrants held by amc and giving effect to the redemption (in exchange for common shares) of all outstanding class c units of trilogy llc, which are redeemable (subject to the expiration of certain &#147;lock-up&#148; periods) either for common shares of the issuer or the cash equivalent thereof, such form of consideration to be determined by trilogy llc (which class c units of trilogy llc have indirect voting rights in the issuer on an as-redeemed basis), or 11.7% based on the total outstanding voting power in the issuer; and (ii) apmflp holds 2,751,000 common shares, and apmflp, apmfgp and amc may be deemed to have shared voting and investment power over these shares, representing 3.3% of outstanding common shares after giving effect to the redemption (in exchange for common shares) of all outstanding class c units of trilogy llc, which are redeemable, and have the voting rights, as described above, or 3.3% based on the total outstanding voting power in the issuer. a joint filing agreement among the reporting persons is attached as exhibit 1 hereto. as a result of the existing relationships described under item 2 and the transactions described in item 3, the reporting persons may be deemed to constitute a &#147;group&#148; within the meaning of rule 13d-5(b) under the exchange act. however, neither the filing of this schedule 13d nor anything contained herein shall be construed as an admission that all or any of the reporting persons constitute a &#147;group&#148; within the meaning of rule 13d-5 (b) under the exchange act. each of the reporting persons is responsible for the completeness and accuracy of the information concerning it contained herein, but is not responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. each of the reporting persons expressly disclaims beneficial ownership of securities held by any person or entity other than, to the extent of any pecuniary interest therein, the various accounts under such reporting person&#146;s management and control. page 6 of 14 pages (c) the information set forth in item 3 is incorporated by reference into this item 5. except as set forth or incorporated by reference into this item 5(c) (including, without limitation, the purchase by apmflp of class b shares of alignvest immediately prior to the consummation of the arrangement) or set forth in schedule a hereto, none of the reporting persons has effected any transactions in the class of securities reported on herein during the past 60 days. (d) and (e) not applicable. item 6. contracts, arrangements, understandings or relationships with respect to securities of the issuer. pursuant to an investor rights agreement dated february 7, 2017 between amc and the issuer (the &#147; investor rights agreement &#148;), amc has certain rights related to the nomination of directors to the board of directors of the issuer (the &#147; board &#148;). amc has the right to nominate two directors to the board for the first two annual general meetings, regardless of the relevant percentage ownership of common shares (as defined below) owned by amc. after such time, amc has the right to nominate two directors to the board for so long as the relevant percentage ownership of common shares owned by amc is greater than 7.5% . if the relevant percentage ownership of common shares owned by amc is less than 7.5% but greater than 5% for any continuous period of at least 30 days, amc will have the right to nominate only one director to the board; and less than 5% for any continuous period of at least 30 days, amc will no longer have the right to nominate a member to the board. for the purposes of the investor rights agreement, the relevant percentage ownership of common shares means: the percentage determined by dividing: (a) the sum of (i) the number of common shares directly or indirectly beneficially owned by amc, but excluding (ii) any other options, warrants, or other securities convertible or exchangeable into or exercisable for common shares; by (b) the sum of (i) the number of issued and outstanding common shares, plus (ii) the number of issued and outstanding class c units of trilogy llc. in addition to the foregoing, following the completion of the arrangement and for as long as amc has the right to nominate at least one director to the board, amc also has the right, acting reasonably, to approve the nomination or appointment of any proposed new independent directors (as defined in the investor rights agreement) to the board that were not approved by all of the then existing independent directors, subject to such proposed new independent directors satisfying certain conditions. page 7 of 14 pages pursuant to a lock-up agreement dated february 7, 2017 between amc and the issuer (the &#147; amc lock-up agreement &#148;), subject to certain exceptions amc may not sell, pledge or otherwise transfer equity securities of the issuer for 24 months after consummation of the arrangement; however, amc may sell up to 50% of amc&#146;s acquired issuer shares in ordinary course arm&#146;s length stock exchange transactions beginning 12 months after consummation of the arrangement. pursuant to a lock-up agreement dated february 7, 2017 between apmflp and the issuer (the &#147; apmflp lock-up agreement &#148;), subject to certain exceptions apmflp may not sell, pledge or otherwise transfer equity securities of the issuer for 24 months after consummation of the arrangement; however, apmflp may sell up to 50% of apmflp&#146;s acquired issuer shares in ordinary course arm&#146;s length stock exchange transactions beginning 12 months after consummation of the arrangement. pursuant to a forfeiture and transfer restriction agreement dated june 24, 2015 between amc and the individuals party thereto, including nadir mohamed, a director of amc (the &#147; forfeiture agreement &#148;), subject to certain exceptions 25% of the founders&#146; shares (as defined therein) owned by each of amc and nadir mohamed (now applicable to the common shares into which the founders&#146; shares have been converted) are subject to forfeiture on the fifth anniversary of the qualifying transaction unless the closing price of the common shares of the issuer exceeds cad$13.00 (subject to adjustment) for any 20 trading days within a 30-day trading period at any time following the closing of the qualifying transaction. the consummation of the arrangement constitutes the qualifying transaction. certain agreements relating to the common shares to which directors or executive officers of the reporting persons are parties are described in schedule a hereto. the foregoing descriptions of the investor rights agreement, the amc lock-up agreement, the apmflp lock-up agreement and the forfeiture agreement do not purport to be complete and are qualified in their entirety by reference to the full text of such documents, which are filed as exhibits 2, 3, 4 and 5 hereto, and incorporated by reference into this item 6. except for the arrangements described in this schedule 13d, the reporting persons are not a party to any contract, arrangement, understanding or relationship with respect to any securities of the issuer, including but not limited to the transfer or voting of any securities of the issuer, finder&#146;s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies. none of the common shares or the warrants held by the reporting persons have been pledged or are otherwise subject to a contingency the occurrence of which would give another person voting power or investment power over such securities. item 7. material to be filed as exhibits 1. joint filing agreement. 2. investor rights agreement, dated as of february 7, 2017, between the issuer and amc. 3. amc lock-up agreement, dated as of february 7, 2017, between the issuer and amc. 4. apmflp lock-up agreement, dated as of february 7, 2017, between the issuer and apmflp. 5. forfeiture agreement, dated as of june 24, 2015, between amc, nadir mohamed and the other individuals party thereto. 6. nadir mohamed lock-up agreement, dated as of february 7, 2017, between the issuer and nadir mohamed. page 8 of 14 pages signature after reasonable inquiry and to the best of my knowledge and belief, i certify that the information set forth in this statement is true, complete and correct. date: february 17, 2017 alignvest management corporation /s/ reza satchu name: reza satchu title: director, managing partner /s/ timothy hodgson name: timothy hodgson title: director, managing partner alignvest partners master fund lp by: alignvest partners master fund gp inc., as general partner /s/ charles thomas name: charles thomas title: director alignvest partners master fund gp inc. /s/ charles thomas name: charles thomas title: director page 9 of 14 pages schedule a information concerning directors and executive officers of alignvest management corporation, alignvest partners master fund lp, and alignvest partners master fund gp inc. alignvest management corporation name of director or executive officer position common shares beneficially owned 1 percentage of outstanding common shares business address principal occupation or employment citizenship lee lau director 0 0 flat b22, f tower 1 37 repulse bay road hong kong, hkg self- employed &#150; manage personal investment holding companies canada, hong kong reza satchu director, managing partner 0 0 director, managing partner of amc canada timothy hodgson director, managing partner 0 0 director, managing partner of amc united states, canada, and united kingdom blake goldring director 0 0 suite 3100, 66 wellington street west m5k 1e9 canada chairman and chief executive officer of agf management limited with its business address as set forth in the preceding column of this schedule a canada andy moysiuk director and partner 0 0 director and partner of amc canada teresa troy director 0 0 suite 1108, 1809 barrington street halifax, nova scotia b3j 3k8 canada chief executive officer of hrm pension plan with its business address as set forth in the preceding column of this schedule a canada ____________________ 1 sole voting power and investment power over all disclosed shares. nadir mohamed director 202,421 which includes 11,629 warrants for common shares 2 0.2% 3 one may street toronto, ontario m4w 2x9 canada corporate director canada sanjil shah chief financial officer and partner 0 0 chief financial officer and partner of amc and director of apmfgp canada alignvest partners master fund lp none alignvest partners master fund gp inc. name of director or executive officer position common shares beneficially owned percentage of outstanding common shares business address principal occupation or employment citizenship charles thomas director 0 0 ugland house grand cayman, cayman islands, ky1- 1104 director of apmfgp united kingdom letitia solomon director 0 0 ugland house grand cayman, cayman islands, ky1- 1104 director of apmfgp cayman islands sanjil shah director 0 0 suite 7050, 100 king street west toronto, ontario m5x 1c7 canada chief financial officer and partner of amc and director of apmfgp canada ____________________ 2 202,421 class b shares of alignvest and 11,629 warrants for class b shares of alignvest previously held by nadir mohamed were acquired contemporaneously with or prior to the 2015 initial public offering of alignvest for an aggregate purchase price of cad$233,215 using personal funds. class b shares and warrants for class b shares were converted upon consummation of the arrangement on february 7, 2017 to the same number of common shares and warrants for common shares. 3 based on 44,177,149 currently outstanding common shares, 11,629 common shares issuable upon exercise of outstanding warrants held by nadir mohamed and 39,334,917 common shares issuable upon redemption (subject to the expiration of certain &#147;lock-up&#148; periods) of currently outstanding class c units of trilogy llc, which class c units of trilogy llc have indirect voting rights in the issuer on an as-redeemed basis. contracts, arrangements, understandings or relationships with respect to securities of the issuer. forfeiture agreement see item 6 of this schedule 13d for a description of the forfeiture agreement to which nadir mohamed, a director of amc, is a party. lock-up agreement pursuant to a lock-up agreement dated february 7, 2017 between nadir mohamed and the issuer (the &#147; nadir mohamed lock-up agreement &#148;), subject to certain exceptions he may not sell, pledge or otherwise transfer equity securities of the issuer for 24 months after consummation of the arrangement; however, he may sell up to 50% of the common shares held by him in ordinary course arm&#146;s length stock exchange transactions beginning 12 months after consummation of the arrangement. the foregoing description of the nadir mohamed lock-up agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such agreement, which is filed as exhibit 6 hereto, and incorporated by reference into this schedule a. bonus and loan arrangements following the consummation of the arrangement, amc intends to pay the following bonuses to certain of its personnel, including certain director and executive officers, who have been instrumental in sourcing and completing the qualifying acquisition (with all common shares owned by amc and nadir mohamed, among others, (collectively, the &#147; founders &#148;) to be reduced proportionately by any forfeiture thereof), and in all cases subject to similar anti-dilution provisions which apply to the issuer&#146;s outstanding warrants for common shares: (a) to sanjil shah, chief financial officer and partner of amc, an amount equal to the value, determined once all contractual resale and forfeiture restrictions have expired, of (i) 12,921 common shares and 6,460.5 of the issuer&#146;s outstanding warrants for common shares, plus (ii) 93,074 founders&#146; common shares (now converted to common shares); (b) to andy moysiuk, a director of amc, an amount equal to the value, determined once all contractual resale and forfeiture restrictions have expired, of (i) 2,992 common shares and 1,496 of the issuer&#146;s outstanding warrants for common shares, plus (ii) 21,551 founders&#146; common shares (now converted to common shares); and (c) to certain other employees who are not officers or directors of either amc or the issuer, an amount equal to the value, determined once all contractual resale and forfeiture restrictions have expired, of (i) 71,162 common shares and 35,581 of the issuer&#146;s outstanding warrants for common shares, plus (ii) 512,578 common shares. in the case of founders&#146; common shares which are subject to forfeiture, if the recipient is not actually engaged by amc for any reason at the date of forfeiture, no bonus shall be payable in respect thereof (in certain cases, death or disability are excluded events). as well, if at any time prior to the date of payment either (i) there is a termination for cause, or (ii) the individual in question breaches any material obligation owed to amc or its affiliates which is not cured within 10 days following written notice thereof, then no bonus shall be owing to the terminated individual. the bonus will be payable in cash and net of withholding or other taxes. the bonus will generally be due in whole or in part following the sale by amc of common shares, provided that after a specified term, amc will have the option to pay in kind. amc owes the following directors and executive officers the amounts specified below on a non-interest bearing basis: (a) cad$103,658 to sanjil shah, chief financial officer and partner of amc; (b) cad$20,004 to andy moysiuk, a director and partner of amc; and (c) a total of cad$214,334 to various other employees or consultants of amc who are officers or directors of either amc or the issuer. the loans in question may be required to be repaid in the discretion of each individual on 30 days&#146; prior written notice following the expiry of all contractual resale and forfeiture restrictions applicable to the common shares owned by amc (or on a pro rata basis as any such restrictions expire in part). following the consummation of the arrangement, the individuals intend to permit amc (subject to any required approvals) to repay the loans as follows. for each cad$10,000 owing, the loan could be repaid either by way of (i) the transfer to the individual of (i) approximately 997 common shares and 499 of the issuer&#146;s outstanding warrants for common shares, plus (ii) approximately 7,183 founders&#146; common shares (reduced proportionately by any forfeiture thereof), and with (i) and (ii) subject to similar anti-dilution provisions which apply to the issuer&#146;s outstanding warrants for common shares, or (ii) the cash equivalent thereof determined as of the date of payment (grossed up for any additional tax payable as a result of paying in cash rather than in securities). in certain cases, if an individual has not required repayment within five years following the consummation of the arrangement, amc may in its discretion elect to repay the loans on the same terms. if an individual receives securities then 50% of the securities received shall be subject to resale restrictions for a 12 month period, which shall be accelerated, on a pro rata basis, in proportion to sales of similar securities by amc from its holdings. certain restrictive covenants apply to the individuals in question. ex-99.1 2 exhibit1.htm exhibit 1 trilogy international partners inc.: exhibit 1 - filed by newsfilecorp.com exhibit 1 joint filing agreement we, the signatories of the statement to which this joint filing agreement is attached, hereby agree that such statement is filed, and any amendments thereto filed by any of us will be filed, on behalf of each of us. dated: february 17, 2017 alignvest management corporation /s/ reza satchu name: reza satchu title: director, managing partner /s/ timothy hodgson name: timothy hodgson title: director, managing partner alignvest partners master fund lp by: alignvest partners master fund gp inc., as general partner /s/ charles thomas name: charles thomas title: director alignvest partners master fund gp inc. /s/ charles thomas name: charles thomas title: director ex-99.2 3 exhibit2.htm exhibit 2 trilogy international partners inc.: exhibit 2 - filed by newsfilecorp.com investor rights agreement this agreement is made as of february 7, 2017 between alignvest management corporation (the &#147; investor &#148;) and trilogy international partners inc. (formerly alignvest acquisition corporation) (&#147; trilogy parent &#148;), a british columbia corporation. whereas : a. the investor is the holder of certain securities of trilogy parent; and b. in connection with an arrangement agreement dated november 1, 2016 between trilogy parent and trilogy international partners llc (as amended december 20, 2016, the &#147; arrangement agreement &#148;), trilogy parent wishes to grant to the investor certain rights to nominate individual(s) identified by the investor for election to the board of directors of trilogy parent, as constituted from time to time (the &#147; trilogy parent board &#148;), in accordance with and subject to the terms and conditions contained in this agreement. now therefore in consideration of the promises, mutual covenants and agreements contained in this agreement, and other good and valuable consideration (the receipt and sufficiency of which is acknowledged by the parties), the parties covenant and agree as follows: 1. interpretation 1.1 definitions. capitalized terms used but not otherwise defined in this agreement will have the meanings ascribed to them in the arrangement agreement. for the purposes of this agreement: &#147; independent director &#148; has the meaning specified in the trilogy llc agreement on the date hereof, without amendment. &#147; relevant percentage ownership of trilogy parent shares &#148; means the percentage determined by dividing: (a) the sum of (i) the number of trilogy parent common shares directly or indirectly beneficially owned by the investor; but excluding (ii) any other options, warrants, or other securities convertible or exchangeable into or exercisable for trilogy parent common shares; by (b) the sum of (i) the number issued and outstanding of trilogy parent common shares; plus (ii) the number issued and outstanding trilogy class c units. &#147; trilogy parent common shares &#148; means common shares in the capital of trilogy parent. &#147; trilogy parent special voting share &#148; means the alignvest special voting share, as defined in the arrangement agreement. &#147; trilogy parent shareholders &#148; means the registered and/or beneficial holders of the trilogy parent common shares and the registered holder of the trilogy parent special voting share. 2. investor nomination rights 2.1 trilogy parent board composition and nominees. subject to section 2.2, 2.3 and 2.4, following the effective date, so long as the relevant percentage ownership of trilogy parent shares owned by the investor is 7.5% or more, the investor will have the right to nominate two directors to the trilogy parent board (together, the &#147; nominees &#148;), as more specifically provided for below: - 2 - (a) each nominee will be nominated and, if elected, serve as a member of the trilogy parent board for a term expiring not earlier than trilogy parent&#146;s next annual meeting of trilogy parent shareholders at which directors of trilogy parent are to be elected, provided that such nominee consents in writing to serve as a director and is eligible to serve as a director under the business corporations act (british columbia) and under the rules of any stock exchange on which the trilogy parent common shares are listed and under any policies and procedures reflecting term limits properly adopted by the trilogy parent board; (b) at the first annual meeting of trilogy parent shareholders following the end of the term of the nominees at which directors of trilogy parent are to be elected, and at each meeting of trilogy parent shareholders thereafter at which directors are to be elected, trilogy parent will cause the nominees to be included in the slate of nominees proposed by trilogy parent to the trilogy parent shareholders for election as directors; (c) trilogy parent will use commercially reasonable efforts to cause the election of the nominees, including soliciting proxies in favour of the election of the nominees in the event trilogy parent intends to solicit any such proxies in connection with a meeting of trilogy parent shareholders; (d) trilogy parent will provide written notice to the investor of not less than 10 days or more than 30 days prior to the record date for trilogy parent shareholders to receive notice of a shareholders meeting at which directors will be elected, containing a reasonably detailed request for information regarding the nominees that is required to be included in an information circular of trilogy parent in respect of the meeting. at least 35 days before such meeting, the investor will deliver to trilogy parent in writing the names of the nominees, together with the information regarding such nominees requested by trilogy parent in accordance with the preceding sentence (the &#147; nominees letter &#148;). if the investor fails to deliver the nominees letter to trilogy parent at least 35 days before the shareholders meeting, the investor will be deemed to have nominated the same nominees that serve as directors of trilogy parent at such time under this provision; (e) if a nominee ceases to hold office as a director of trilogy parent for any reason, the investor will be entitled to nominate an individual to replace him or her and, subject to such individual satisfying the requirements specified in section 2.1(a) above, trilogy parent will promptly take all reasonable steps as may be necessary to appoint such individual to the trilogy parent board to replace the nominee who has ceased to hold office; (f) trilogy parent will not be entitled to veto a nominee provided that such nominee has not previously been removed by a resolution of the trilogy parent shareholders and is not a director who retired by rotation and was not re-elected by the trilogy parent shareholders; (g) so long as a nominee serves as a member of the trilogy parent board, such nominee will be eligible to serve on any committee of the trilogy parent board provided that such nominee satisfies the eligibility criteria for such committee and the trilogy parent board has approved, and has received regulatory approval, of the nominee serving as a member of such committee; and - 3 - (h) the nominees will, unless they are executive officers of trilogy parent or its subsidiaries (including trilogy and its subsidiaries) be compensated as members of the trilogy parent board on a basis no less favourable than the basis upon which trilogy parent compensates the other members of the trilogy parent board, unless they are executive officers of trilogy parent or its subsidiaries (including trilogy and its subsidiaries). 2.2 notwithstanding section 2.1, but subject to section 2.3, if at any time the relevant percentage ownership of trilogy parent shares owned by the investor is: (a) less than 7.5% but greater than 5% for any continuous period of at least 30 days, the investor will have the right to nominate only one director to the trilogy parent board; and (b) less than 5% for any continuous period of at least 30 days, the investor will no longer have the right to nominate a member to the trilogy parent board. 2.3 notwithstanding sections 2.1 and 2.2, during the period of time from the effective date to the end of the second annual general meeting of trilogy parent following the effective time, the investor will have the right to nominate two directors to the trilogy parent board regardless of the relevant percentage ownership of trilogy parent shares owned by the investor. 2.4 following the effective date and for as long as the investor has the right to nominate at least one director to the trilogy parent board, the investor shall also have the right, acting reasonably, to approve the nomination or appointment of any proposed new independent directors to the trilogy parent board that were not approved by all of the then existing independent directors, subject to such proposed new independent directors: (i) satisfying the requirements specified in section 2.1(a) above; (ii) satisfying all applicable audit committee independence requirements under applicable securities laws and stock exchange rules; and (iii) not directly or indirectly owning any trilogy class c units. 3. general 3.1 independent legal advice. the investor acknowledges that he has been advised to seek independent legal advice with respect to the matters contained in this agreement and has either obtained such advice or has waived his right to do so. 3.2 further assurances. the parties will execute all other documents and instruments and do all other things necessary to implement and carry out the terms of this agreement. 3.3 amendment or waiver. this agreement will not be amended except by written agreement that is signed by the parties. no waiver of any obligation or any breach of any provision of this agreement will be effective or binding unless made in writing and signed by the party purporting to give the same and, unless otherwise provided, will be limited to the specific obligation or breach waived. 3.4 severability. should any part of this agreement be declared or held to be invalid for any reason, the invalidity will not affect the validity of the remainder of this agreement which will continue in full force and effect and be construed as if this agreement had been executed without the invalid portion and it is hereby declared the intention of the parties that this agreement would have been executed without reference to any portion that may, for any reason, be hereafter declared or held invalid. - 4 - 3.5 enurement. this agreement will be binding upon and enure to the benefit of the parties and their respective heirs, executors, administrators, personal representatives, successors and permitted assigns (as applicable). 3.6 assignment. neither party may assign or transfer any of its interest in this agreement without the prior written consent of the other party. 3.7 governing law and jurisdiction. this agreement will be governed by and interpreted in accordance with the laws of the province of british columbia and the laws of canada applicable in british columbia. each party hereby irrevocably submits to the jurisdiction of the courts of the province of british columbia for the purpose of any judicial proceeding arising out of or relating to or concerning this agreement. 3.8 entire agreement. this agreement constitutes the entire agreement between the parties with respect to the subject matter of this agreement and supersedes all previous communications, representations and agreements, whether verbal or written, between the parties with respect to the subject matter of this agreement. 3.9 counterparts. this agreement may be executed in counterparts, each of which when executed and delivered (by facsimile or otherwise) will be deemed to be an original, and both of which together will constitute one and the same document. [signature page follows] in witness whereof the parties have executed this agreement as of the date first written above. alignvest management corporation by: /s/ reza satchu name: reza satchu title: chairman, chief executive officer, managing partner and director trilogy international partners inc. by: /s/ scott morris name: scott morris title: senior vice president, general counsel and corporate secretary signature page -amc investor rights agreement ex-99.3 4 exhibit3.htm exhibit 3 trilogy international partners inc.: exhibit 3 - filed by newsfilecorp.com lock-up agreement this agreement is made as of february 7, 2017 between trilogy international partners inc. (formerly alignvest acquisition corporation) (&#147; trilogy parent &#148;) and the person signing below (the &#147; locked-up shareholder &#148;). whereas trilogy parent and trilogy international partners llc (&#147; trilogy subsidiary &#148;) are parties to an arrangement agreement dated november 1, 2016 (as amended december 20, 2016, the &#147; arrangement agreement &#148;) and it is a condition to the completion of the transactions contemplated in the arrangement agreement that the locked-up shareholder agrees to enter into this agreement in favour of trilogy parent. now therefore in consideration of the promises, mutual covenants and agreements contained in this agreement, and other good and valuable consideration (the receipt and sufficiency of which is acknowledged by the parties), the parties covenant and agree as follows: 1. interpretation 1.1 definitions. capitalized terms used but not otherwise defined in this agreement will have the meanings ascribed to them in the arrangement agreement. for purposes of this agreement: &#147; trilogy parent shares &#148; means alignvest shares, as defined in the arrangement agreement. &#147; trilogy parent warrants &#148; means alignvest warrants, as defined in the arrangement agreement. 2. lock-up 2.1 subject to the completion of the arrangement, the locked-up shareholder shall not, without the prior written consent of trilogy parent, such consent not to be unreasonably withheld or delayed: (a) sell, assign, pledge, dispose of, or transfer any equity securities of trilogy parent or securities convertible into or exchangeable for equity securities of trilogy parent (including trilogy parent shares and trilogy parent warrants), or any rights associated therewith, in each case as held or acquired on or after the effective time (but expressly excluding any securities acquired pursuant to an alignvest additional subscription agreement)(collectively the &#147; specified securities &#148;); (b) enter into any swap, forward or other arrangement that transfers all or a portion of the economic consequences associated with the ownership of the specified securities (regardless of whether any such arrangement is to be settled by the delivery of securities of trilogy parent or trilogy subsidiary, securities of another person, cash and/or otherwise); or (c) or agree to do any of the foregoing, in each case, at any time after the effective time until the date that is twenty-four (24) months after the effective time. 2.2 the foregoing restrictions shall not apply to: (a) transfers to wholly-owned affiliated entities of the undersigned (so long as such affiliated entity remains an affiliate of the undersigned), any family members of the undersigned, or any company, trust or other entity owned by or maintained for the benefit of the undersigned; (b) transfers occurring by operation of law or in connection with transactions arising as a result of the death or incapacitation of the undersigned; (c) pledges of the specified securities to a financial institution as security for bona fide indebtedness of the undersigned, provided, in each case of the foregoing (a) through (c), that any such transferee or pledgee shall first execute a lock-up agreement in substantially the form hereof covering the remainder of the period of time that such specified securities are subject to the restrictions contained in this lock-up agreement; (d) the exercise of securities granted under the management incentive plan (if any); or (e) transfers made pursuant to a bona fide take-over bid or similar transaction made to all holders of common shares of trilogy parent provided that in the event the take-over or acquisition transaction is not completed, any securities shall remain subject to the restrictions contained in this lock-up agreement. - 2 - 2.3 notwithstanding the foregoing, the locked-up shareholder may sell up to 50% of the trilogy parent common shares underlying the specified securities in ordinary course arm&#146;s length stock exchange transactions on and after the date that is twelve (12) months after the effective time. 3. miscellaneous 3.1 independent legal advice. the locked-up shareholder acknowledges that he or she has been advised to seek independent legal advice with respect to the matters contained in this agreement and has either obtained such advice or has waived his or her right to do so. 3.2 further assurances. the parties will execute all other documents and instruments and do all other things necessary to implement and carry out the terms of this agreement. 3.3 amendment or waiver. this agreement will not be amended except by written agreement that is signed by the parties. no waiver of any obligation or any breach of any provision of this agreement will be effective or binding unless made in writing and signed by the party purporting to give the same and, unless otherwise provided, will be limited to the specific obligation or breach waived. 3.4 severability. should any part of this agreement be declared or held to be invalid for any reason, the invalidity will not affect the validity of the remainder of this agreement which will continue in full force and effect and be construed as if this agreement had been executed without the invalid portion and it is hereby declared the intention of the parties that this agreement would have been executed without reference to any portion that may, for any reason, be hereafter declared or held invalid. 3.5 enurement. this agreement will be binding upon and enure to the benefit of the parties and their respective heirs, executors, administrators, personal representatives, successors and permitted assigns (as applicable). 3.6 assignment. neither party may assign or transfer any of its interest in this agreement without the prior written consent of the other party. 3.7 governing law and jurisdiction. this agreement will be governed by and interpreted in accordance with the laws of the province of british columbia and the laws of canada applicable in british columbia. each party hereby irrevocably submits to the jurisdiction of the courts of the province of british columbia for the purpose of any judicial proceeding arising out of or relating to or concerning this agreement. 3.8 entire agreement. this agreement constitutes the entire agreement between the parties with respect to the subject matter of this agreement and supersedes all previous communications, representations and agreements, whether verbal or written, between the parties with respect to the subject matter of this agreement. 3.9 counterparts. this agreement may be executed in counterparts, each of which when executed and delivered (by facsimile or otherwise) will be deemed to be an original, and both of which together will constitute one and the same document. [signature page follows] in witness whereof the parties have executed this agreement as of the date first written above. alignvest management corporation by: /s/ reza satchu name: reza satchu title: chairman, chief executive officer, managing partner and director trilogy international partners inc. by: /s/ scott morris name: scott morris title: senior vice president, general counsel and corporate secretary signature page - lock-up agreement ex-99.4 5 exhibit4.htm exhibit 4 trilogy international partners inc.: exhibit 4 - filed by newsfilecorp.com lock-up agreement this agreement is made as of february 7, 2017 between trilogy international partners inc. (formerly alignvest acquisition corporation) (&#147; trilogy parent &#148;) and the person signing below (the &#147; locked-up shareholder &#148;). whereas trilogy parent and trilogy international partners llc (&#147; trilogy subsidiary &#148;) are parties to an arrangement agreement dated november 1, 2016 (as amended december 20, 2016, the &#147; arrangement agreement &#148;) and it is a condition to the completion of the transactions contemplated in the arrangement agreement that the locked-up shareholder agrees to enter into this agreement in favour of trilogy parent. now therefore in consideration of the promises, mutual covenants and agreements contained in this agreement, and other good and valuable consideration (the receipt and sufficiency of which is acknowledged by the parties), the parties covenant and agree as follows: 1. interpretation 1.1 definitions. capitalized terms used but not otherwise defined in this agreement will have the meanings ascribed to them in the arrangement agreement. for purposes of this agreement: &#147; trilogy parent shares &#148; means alignvest shares, as defined in the arrangement agreement. &#147; trilogy parent warrants &#148; means alignvest warrants, as defined in the arrangement agreement. 2. lock-up 2.1 subject to the completion of the arrangement, the locked-up shareholder shall not, without the prior written consent of trilogy parent, such consent not to be unreasonably withheld or delayed: (a) sell, assign, pledge, dispose of, or transfer any equity securities of trilogy parent or securities convertible into or exchangeable for equity securities of trilogy parent (including trilogy parent shares and trilogy parent warrants), or any rights associated therewith, in each case as held or acquired on or after the effective time (but expressly excluding any securities acquired pursuant to an alignvest additional subscription agreement)(collectively the &#147; specified securities &#148;); (b) enter into any swap, forward or other arrangement that transfers all or a portion of the economic consequences associated with the ownership of the specified securities (regardless of whether any such arrangement is to be settled by the delivery of securities of trilogy parent or trilogy subsidiary, securities of another person, cash and/or otherwise); or (c) or agree to do any of the foregoing, in each case, at any time after the effective time until the date that is twenty-four (24) months after the effective time. 2.2 the foregoing restrictions shall not apply to: (a) transfers to wholly-owned affiliated entities of the undersigned (so long as such affiliated entity remains an affiliate of the undersigned), any family members of the undersigned, or any company, trust or other entity owned by or maintained for the benefit of the undersigned; (b) transfers occurring by operation of law or in connection with transactions arising as a result of the death or incapacitation of the undersigned; (c) pledges of the specified securities to a financial institution as security for bona fide indebtedness of the undersigned, provided, in each case of the foregoing (a) through (c), that any such transferee or pledgee shall first execute a lock-up agreement in substantially the form hereof covering the remainder of the period of time that such specified securities are subject to the restrictions contained in this lock-up agreement; (d) the exercise of securities granted under the management incentive plan (if any); or (e) transfers made pursuant to a bona fide take-over bid or similar transaction made to all holders of common shares of trilogy parent provided that in the event the take-over or acquisition transaction is not completed, any securities shall remain subject to the restrictions contained in this lock-up agreement. - 2 - 2.3 notwithstanding the foregoing, the locked-up shareholder may sell up to 50% of the trilogy parent common shares underlying the specified securities in ordinary course arm&#146;s length stock exchange transactions on and after the date that is twelve (12) months after the effective time. 3. miscellaneous 3.1 independent legal advice. the locked-up shareholder acknowledges that he or she has been advised to seek independent legal advice with respect to the matters contained in this agreement and has either obtained such advice or has waived his or her right to do so. 3.2 further assurances. the parties will execute all other documents and instruments and do all other things necessary to implement and carry out the terms of this agreement. 3.3 amendment or waiver. this agreement will not be amended except by written agreement that is signed by the parties. no waiver of any obligation or any breach of any provision of this agreement will be effective or binding unless made in writing and signed by the party purporting to give the same and, unless otherwise provided, will be limited to the specific obligation or breach waived. 3.4 severability. should any part of this agreement be declared or held to be invalid for any reason, the invalidity will not affect the validity of the remainder of this agreement which will continue in full force and effect and be construed as if this agreement had been executed without the invalid portion and it is hereby declared the intention of the parties that this agreement would have been executed without reference to any portion that may, for any reason, be hereafter declared or held invalid. 3.5 enurement. this agreement will be binding upon and enure to the benefit of the parties and their respective heirs, executors, administrators, personal representatives, successors and permitted assigns (as applicable). 3.6 assignment. neither party may assign or transfer any of its interest in this agreement without the prior written consent of the other party. 3.7 governing law and jurisdiction. this agreement will be governed by and interpreted in accordance with the laws of the province of british columbia and the laws of canada applicable in british columbia. each party hereby irrevocably submits to the jurisdiction of the courts of the province of british columbia for the purpose of any judicial proceeding arising out of or relating to or concerning this agreement. 3.8 entire agreement. this agreement constitutes the entire agreement between the parties with respect to the subject matter of this agreement and supersedes all previous communications, representations and agreements, whether verbal or written, between the parties with respect to the subject matter of this agreement. 3.9 counterparts. this agreement may be executed in counterparts, each of which when executed and delivered (by facsimile or otherwise) will be deemed to be an original, and both of which together will constitute one and the same document. [signature page follows] in witness whereof the parties have executed this agreement as of the date first written above. alignvest partners master fund lp by: /s/ charles thomas name: charles thomas title: director by: /s/ letitia solomon name: letitia solomon title: director trilogy international partners inc. by: /s/ scott morris name: scott morris title: senior vice president, general counsel and corporate secretary signature page -lock-up agreement ex-99.5 6 exhibit5.htm exhibit 5 trilogy international partners inc.: exhibit 5 - filed by newsfilecorp.com for f eiture and transfer restrictions agreement and undertaking to: alignvest acquisition corporation (the "corporation") and to: td securities inc. and cantor fitzgerald &amp; co., as joint book-runners (together, the "joint book-runners"), each on their own behalf and on behalf of the underwriting syndicate and to: toronto stock exchange ("tsx") re: forfeiture and 1transfer restrictions pursuant to the corporation's final prospectus, date(l june 16, 2015 (the "prospectus") whereas alignvest management corporation, as the sponsor of the corporation (the "sponsor"), bonnie brooks, vince hemmer (as granter and trustee of vincent j. hemmer revocable trust dated june 14, 2002), adam jiwan, nadir mohamed and donald walker (collectively, and together with the sponsor, the "founders", and each a "founder"), have collectively purchased 6,701,344 class b shares of the corporation (the "founders' shares") (before taking into account the class b shares (as defined herein) forming part of the class b units (as defined herein) purchased pursuant to the prospectus), for an aggregate price of $25,000, or approximately $0.0037 per founders' share, or $0.0043 per founders' share if the over-allotment option (as defined below) is not exercised; and whereas pursuant to the prospectus, the corporation has offered to the public in its initial public offering (the "offering") 22,500,000 class a restricted voting units of the corporation (or 25,875,000 class a restricted voting units if the over-allotment option is exercised in full) (the ''class a restricted voting units"), at an offering price of $10.00 per class a restricted voting unit, for an aggregate purchase price of $225,000,000 (or $258,750,000 if the over-allotment option is exercised in full); and whereas pursuant to the prospectus, the founders will purchase an aggregate of 846,000 class b units of the corporation (or 930,375 class b units if the over-allotment option is exercised in full) (the "class b units") at an offering price of $10.00 per class b unit, for an aggregate purchase price of $8,460,000 (or $9,303,750 if the over-allotment option is exercised in full); and whereas each class a restricted voting unit consists of one class a restricted voting share of the corporation (the "class a restricted voting shares") and one-half of a share purchase warrant (each whole purchase warrant being a "warrant"); and whereas each class b unit consists of one class b share of the corporation (the "class b shares") and one-half of a warrant; - 2 - and whereas the corporation has granted to the underwriters a non-transferable option to purchase up to an additional 3,375,000 class a restricted voting units, at a price of $10.00 per class a restricted voting unit, exercisable for a period of 30 days from the closing date of the offering, to cover over-allotments, if any, and for market stabilization purposes (the "over-allotment option"); and whereas each of the founders has agreed to certain forfeiture and transfer restrictions on his/her/its respective founders' shares and class b units (including the class b shares and warrants underlying his/her/its class b units), all as outlined in greater detail herein; now therefore in consideration of the foregoing and the mutual agreements contained herein (the receipt and adequacy of which are acknowledged), the parties agree as follows: section 1 certain defined terms in addition to other terms defined elsewhere in this agreement and undertaking, the following terms have the following meanings: "agreement and undertaking" means this forfeiture and transfer restrictions agreement and undertaking; "escrow agent" means equity financial trust company of canada; "escrow agreement" means the escrow agreement entered into among the corporation, each of the joint book-runners, and the escrow agent, as it may be amended, restated or assigned; "extraordinary dividend" means any dividend, together with all other dividends payable in the same calendar year, that has an aggregate absolute dollar value which is greater than $0.25 per share, with the adjustment to the applicable price (as the context may require) being a reduction equal to the amount of the excess; "permitted timeline" means 21 months from the closing of the offering (or 24 months from the closing of the offering if the corporation has executed a letter of intent, agreement in principle or definitive agreement for a qualifying acquisition within 21 months from the closing of the offering but has not completed the qualifying acquisition within such 21-month period), which may be extended on written notice by the corporation to the escrow agent to up to 36 months with shareholder approval, by ordinary resolution of the holders of the class a restricted voting shares, with approval by the corporation's board of directors, and with the consent (ifrequired) of the tsx; "qualifying acquisition" means a qualifying acquisition within the meaning of part x of the tsx company manual (as amended from time to time, and subject to any exemptive relief granted by the tsx); and "transfer" means the sale of, offer to sell, contract or agreement to sell, assign, convey or transfer, hypothecate, pledge, grant of any option to purchase or otherwise dispose of, directly or indirectly, any right, title or interest, or the economic benefits thereof, and includes the public announcement of the intent to undertake any of the foregoing. - 3 - capitalized terms used herein but not defined have the meanings ascribed thereto in the prospectus. section 2 transfer restrictions founders' shares: each of the founders hereby undertakes and agrees as follows: (1) subject to section 2(3) and section 3, such founder will not transfer any of his/her/its founders' shares prior to completion of the qualifying acquisition of the corporation without the prior consent of the corporation, the joint book-runners and the tsx; (2) subject to section 2(3) and section 3, following the qualifying acquisition, such founder, without the prior consent of the corporation, the joint book-runners and the tsx, will not transfer any of his/her/its founders' shares until the earlier of: (a) one year following completion of the qualifying acquisition, and (b) the closing share price of the class b shares equaling or exceeding $12.00 per share (as adjusted for stock splits or combinations, stock dividends, extraordinary dividends, reorganizations and recapitalizations) for any 20 trading days within a 30-trading day period at any time following the closing of the qualifying acquisition, subject to applicable securities laws, tsx rules and applicable escrow requirements; and (3) notwithstanding the foregoing clauses, such founder may transfer his/her/its founders' shares if required due to the structuring of a qualifying acquisition, and in such case, this agreement and undertaking will apply to any securities received by such founder in connection with the qualifying acquisition (including, but not limited to, any securities received by such founder pursuant to any reclassification, sub-division, consolidation, conversion, exchange, extraordinary dividend or distribution, or stock dividend or distribution). such founder further acknowledges that following completion of the qualifying acquisition, his/her/its respective founders' shares may be subject to certain sale, transfer or escrow restrictions in accordance with applicable securities laws and tsx rules. class b units (and class b shares and warrants underlying the class b units): in addition to the foregoing, each of the founders hereby undertakes and agrees as follows: (4) subject to section 2(5), such founder will not transfer any of his/her/its class b units (or any of his/her/its class b shares or warrants underlying his/her/its class b units) until the date that is 30 days after the closing of the qualifying acquisition without the prior consent of the corporation, the joint book-runners and the tsx. in addition to his/her/its acknowledgment in section 2(3) in respect of his/her/its founders' shares, such founder acknowledges that following completion of the qualifying acquisition, his/her/its class b units (including the class b shares and warrants underlying those class b units, and the shares issuable on exercise of such warrants) may be subject to certain sale or transfer restrictions in accordance with applicable securities laws; and - 4 - (5) notwithstanding the foregoing clause, such founder may transfer his/her/its class b units (or any of his/her/its class b shares or warrants underlying his/her/its class b units) if required due to the structuring of a qualifying acquisition, and in such case, this agreement and undertaking will apply to any securities received by such founder in connection with the qualifying acquisition (including, but not limited to, any securities received by such founder pursuant to any reclassification, sub-division, consolidation, conversion, exchange, extraordinary dividend or distribution, or stock dividend or distribution). general: each of the founders hereby undertakes and agrees as follows: (6) in the event that the required consent of the corporation, the joint book-runners and the tsx is obtained to permit a transfer in accordance with this agreement and undertaking, as a condition to such transfer, the undersigned shall cause any such transferee of his/her/its respective securities to become a party to this agreement and undertaking and be bound by the terms and conditions herein; and (7) any transfer permitted by consent granted hereunder shall comply with applicable securities laws. section 3 forfeiture restrictions founders: each of the founders hereby undertakes and agrees as follows: (1) up to 864,844 of the founders' shares, based on each founder's pro-rata ownership portion of the founders' shares, are subject to forfeiture by the undersigned or his/her/its affiliates without compensation, depending on the extent to which the over-allotment option is exercised, such that the pro-forma ownership of the founders' shares following any exercise of the over-allotment option, partially or in full, or if there is no exercise of the over-allotment option, would represent 20% of the issued and outstanding shares of the corporation (including all class a restricted voting shares and class b shares, but assuming no exercise of the warrants); (2) 25% of the founders' shares held by each of the founders, including such founder, representing an aggregate of 5% of the shares issued and outstanding immediately following the conclusion of the over-allotment option period (the "founders' forfeiture shares"), will be subject to forfeiture by the founders on the fifth anniversary of the qualifying acquisition unless the closing share price of the class b shares exceeds $13.00 (as adjusted for stock splits or combinations, stock dividends, extraordinary dividends, reorganizations and recapitalizations) for any 20 trading days within a 30- trading day period at any time following the closing of the qualifying acquisition; - 5 - (3) at such time as the foregoing $13.00 closing class b share price forfeiture condition is satisfied, the founders' forfeiture shares will, as applicable, become subject to the same ongoing restrictions applicable to the other founders' shares at that time. notwithstanding section 2, the founders' forfeiture shares cannot be transferred until fulfillment of the foregoing conditions in section 3(2) and subject to all of the restrictions applicable to the other founders' shares herein; and (4) notwithstanding the foregoing clauses, such founder may transfer his/her/its founders' shares (including, for greater certainty, his/her/its founders' forfeiture shares) if required due to the structuring of a qualifying acquisition, and in such case, this agreement and undertaking will apply to any securities received by such founder in connection with the qualifying acquisition (including, but not limited to, any securities received by such founder pursuant to any reclassification, sub-division, consolidation, conversion, exchange, extraordinary dividend or distribution, or stock dividend or distribution). section 4 additional undertakings each of the founders hereby further agrees as follows: (1) such founder will not propose any amendment to the corporation's articles of incorporation prior to the closing of a qualifying acquisition that would materially adversely affect the redemption rights of the holders of class a restricted voting shares, unless the escrow agreement has been amended to provide holders of class a restricted voting shares with redemption rights, should such amendment of the articles proceed, that are substantially equivalent to the redemption rights that would apply to redemptions on the extension of the permitted timeline; and (2) such founder has no right, title, interest or claim of any kind in or to any monies held in the escrow account or any other assets of the corporation as a result of any liquidation of the corporation with respect to his/her/its founders' shares or his/her/its class b shares forming part of the class b units, provided that such founder shall be entitled to redemption rights (in addition to all other rights provided to holders of class a restricted voting shares) with respect to any class a restricted voting share it holds or may hold. section 5 successor and assigns this agreement and undertaking shall become binding upon and enure to the benefit of the parties and their respective successors and permitted assigns. section 6 severability if any provision of this agreement and undertaking shall be determined by any court of competent jurisdiction to be illegal, invalid or unenforceable, that provision shall be severed from this agreement and undertaking and the remaining provisions shall continue in full force and effect. -6- section 7 governing law this agreement and undertaking shall be governed by and interpreted and enforced in accordance with the laws of the province of ontario and the federal laws of canada applicable therein. section 8 counterparts this agreement and undertaking may be executed in any number of counterparts (including counterparts by facsimile), and all such counterparts taken together shall be deemed to constitute one and the same instrument. [remainder of this page intentionally left blank. signature page follows.] dated this 24 th day of june, 2015. alignvest management corporation, as founder and the sponsor by: /s/ reza satchu by: /s/ lee lau /s/ witness /s/ bonnie brooks witness bonnie brooks, as founder /s/ witness /s/ vince hemmer witness vince hemmer, as founder /s/ witness /s/ adam jiwan witness adam jiwan, as founder /s/ witness /s/ nadir mohamed witness nadir mohamed, as founder /s/ witness /s/ donald walker witness donald walker, as founder forfeitztre and transfer restrictions agreement and undertaking ex-99.6 7 exhibit6.htm exhibit 6 trilogy international partners inc.: form sc 13d- filed by newsfilecorp.com lock-up agreement this agreement is made as of february 7, 2017 between trilogy international partners inc. (formerly alignvest acquisition corporation) (&#147; trilogy parent &#148;) and the person signing below (the &#147; locked-up shareholder &#148;). whereas trilogy parent and trilogy international partners llc (&#147; trilogy subsidiary &#148;) are parties to an arrangement agreement dated november 1, 2016 (as amended december 20, 2016, the &#147; arrangement agreement &#148;) and it is a condition to the completion of the transactions contemplated in the arrangement agreement that the locked-up shareholder agrees to enter into this agreement in favour of trilogy parent. now therefore in consideration of the promises, mutual covenants and agreements contained in this agreement, and other good and valuable consideration (the receipt and sufficiency of which is acknowledged by the parties), the parties covenant and agree as follows: 1. interpretation 1.1 definitions. capitalized terms used but not otherwise defined in this agreement will have the meanings ascribed to them in the arrangement agreement. for purposes of this agreement: &#147; trilogy parent shares &#148; means alignvest shares, as defined in the arrangement agreement. &#147; trilogy parent warrants &#148; means alignvest warrants, as defined in the arrangement agreement. 2. lock-up 2.1 subject to the completion of the arrangement, the locked-up shareholder shall not, without the prior written consent of trilogy parent, such consent not to be unreasonably withheld or delayed: (a) sell, assign, pledge, dispose of, or transfer any equity securities of trilogy parent or securities convertible into or exchangeable for equity securities of trilogy parent (including trilogy parent shares and trilogy parent warrants), or any rights associated therewith, in each case as held or acquired on or after the effective time (but expressly excluding any securities acquired pursuant to an alignvest additional subscription agreement) (collectively the &#147; specified securities &#148;); (b) enter into any swap, forward or other arrangement that transfers all or a portion of the economic consequences associated with the ownership of the specified securities (regardless of whether any such arrangement is to be settled by the delivery of securities of trilogy parent or trilogy subsidiary, securities of another person, cash and/or otherwise); or (c) or agree to do any of the foregoing, in each case, at any time after the effective time until the date that is twenty-four (24) months after the effective time. 2.2 the foregoing restrictions shall not apply to: (a) transfers to wholly-owned affiliated entities of the undersigned (so long as such affiliated entity remains an affiliate of the undersigned), any family members of the undersigned, or any company, trust or other entity owned by or maintained for the benefit of the undersigned; (b) transfers occurring by operation of law or in connection with transactions arising as a result of the death or incapacitation of the undersigned; (c) pledges of the specified securities to a financial institution as security for bona fide indebtedness of the undersigned, provided, in each case of the foregoing (a) through (c), that any such transferee or pledgee shall first execute a lock-up agreement in substantially the form hereof covering the remainder of the period of time that such specified securities are subject to the restrictions contained in this lock-up agreement; (d) the exercise of securities granted under the management incentive plan (if any); or (e) transfers made pursuant to a bona fide take-over bid or similar transaction made to all holders of common shares of trilogy parent provided that in the event the take-over or acquisition transaction is not completed, any securities shall remain subject to the restrictions contained in this lock-up agreement. 2.3 notwithstanding the foregoing, the locked-up shareholder may sell up to 50% of the trilogy parent common shares underlying the specified securities in ordinary course arm&#146;s length stock exchange transactions on and after the date that is twelve (12) months after the effective time. - 2 - 3. miscellaneous 3.1 independent legal advice. the locked-up shareholder acknowledges that he or she has been advised to seek independent legal advice with respect to the matters contained in this agreement and has either obtained such advice or has waived his or her right to do so. 3.2 further assurances. the parties will execute all other documents and instruments and do all other things necessary to implement and carry out the terms of this agreement. 3.3 amendment or waiver. this agreement will not be amended except by written agreement that is signed by the parties. no waiver of any obligation or any breach of any provision of this agreement will be effective or binding unless made in writing and signed by the party purporting to give the same and, unless otherwise provided, will be limited to the specific obligation or breach waived. 3.4 severability. should any part of this agreement be declared or held to be invalid for any reason, the invalidity will not affect the validity of the remainder of this agreement which will continue in full force and effect and be construed as if this agreement had been executed without the invalid portion and it is hereby declared the intention of the parties that this agreement would have been executed without reference to any portion that may, for any reason, be hereafter declared or held invalid. 3.5 enurement. this agreement will be binding upon and enure to the benefit of the parties and their respective heirs, executors, administrators, personal representatives, successors and permitted assigns (as applicable). 3.6 assignment. neither party may assign or transfer any of its interest in this agreement without the prior written consent of the other party. 3.7 governing law and jurisdiction. this agreement will be governed by and interpreted in accordance with the laws of the province of british columbia and the laws of canada applicable in british columbia. each party hereby irrevocably submits to the jurisdiction of the courts of the province of british columbia for the purpose of any judicial proceeding arising out of or relating to or concerning this agreement. 3.8 entire agreement. this agreement constitutes the entire agreement between the parties with respect to the subject matter of this agreement and supersedes all previous communications, representations and agreements, whether verbal or written, between the parties with respect to the subject matter of this agreement. 3.9 counterparts. this agreement may be executed in counterparts, each of which when executed and delivered (by facsimile or otherwise) will be deemed to be an original, and both of which together will constitute one and the same document. [signature page follows] in witness whereof the parties have executed this agreement as of the date first written above. witness /s/ nadir mohamed witness name name: nadir mohamed /s/ witness witness signature trilogy international partners inc. by: /s/ scott morris name: scott morris title: senior vice president, general counsel and corporate secretary 